The repurchase plan is in addition to a separate $400 million repurchasing program the company began in August 2022, which is expected to be completed by the end of the first quarter, according to a Feb. 13 news release.
The $400 million authorization will allow the company to buy back about 3.8 percent of its more than 131 million outstanding shares at the current stock price.
The stock purchases will be occasionally made on the open market and through negotiated transactions, the release said.
At the Becker's 5th Annual Future of Dentistry Roundtable, taking place September 14-15 in Chicago, dental leaders and executives will gain insights into emerging technologies, practice growth strategies and the evolving landscape of dental care delivery, with a focus on innovation, patient experience and operational excellence. Apply for complimentary registration now.
